Lowest Price Guaranteed From USD 4,799
Published
January 2023
Pages
659
View Count
38418
Example Insights
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Report Description
In order to meet the anticipated future demand for biologics fill / finish services in the American and European markets, contract service providers based in these regions have made significant investments in accruing additional capacity for drug product manufacturing and fill / finish
-- Chief Commercial Officer, large-sized company
The biologics fill finish manufacturing market, representing the opportunity for contract manufacturers, is estimated to be USD 4 billion in 2022. The global market size is anticipated to grow at a CAGR of 8.4% during the forecast period. The advent of biologics marked the beginning of a new era in the pharmaceutical industry. Over time, the growing promise of biopharmaceuticals has captured the interest of various industry and academic stakeholders. Currently, more than 200 biologics are commercially available and over 10,000 candidates are under clinical evaluation. With the increasing demand and diversity of biologics, an increase in the demand for production capacity and aseptic fill finish operations has been observed. Fill/finish refers to the process of filling the final drug products in sterile packaging containers (including vials, syringes, ampoules and cartridges). Of all the steps involved in the production of biologics, fill-finish is amongst the most critical steps and a heavily outsourced operation. In fact, even a minute error during the fill/finish process can lead to microbial contamination, which can subsequently result in the loss of drug product, production delays and, most importantly, pose risk to the patient’s health. As a result, various stakeholders are turning to contract manufacturing organizations for their fill/finish related requirements and necessary infrastructure, to ensure the development of quality drug products. Driven by the growing demand for biopharmaceuticals, the biologics fill finish manufacturing market is anticipated to witness substantial growth during the forecast period.
The Biologics Fill Finish Manufacturing Market (3rd Edition) by Type of Packaging Containers (Ampoules, Cartridges, Syringes and Vials), Type of Biologics (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Large, Mid-sized and Small), Key Therapeutic Areas (Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Infectious Diseases and Other Disorders), Geographical Regions (North America, Europe, Asia Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2022-2035 market report features an extensive study of the current market landscape, market size, market forecast and future opportunities associated with the biopharmaceuticals fill finish market, during the given forecast period. The research report highlights efforts of several contract manufacturing organizations engaged in this rapidly emerging segment of the biopharmaceuticals manufacturing industry. Key takeaways of the biologics fill finish manufacturing market are briefly discussed below.
With the growing pipeline of biologics, the demand for contract services for development and fill/finish has increased. Currently, close to 180 companies offer fill finish manufacturing services for a wide range of biologics. In terms of geographical presence, we have identified more than 350 fill-finish facilities of these contract manufacturing organizations. Majority of the facilities are located in Europe, followed by North America and Asia Pacific.
Nearly 70% of the companies have the capability to operate at all the scales of operation from preclinical to commercial. Additionally, the companies have capability to work with different types of biologics including peptides, antibodies, vaccines, cell therapy, gene therapy, nucleic acids, plasmid DNA, antibody drug conjugates, biosimilars and others.
The biopharmaceutical industry has witnessed substantial number of partnerships and collaborations between drug developers and fill/finish contract manufacturing organizations over the last few years. The COVID 19 pandemic also led to an increase in the demand for fill finish of vaccines, leading to a rise in the number of service agreements. For fulfilling the demand for its COVID vaccine in Europe, Pfizer and BioNTech collaborated with Delpharm, Thermo Fisher Scientific and more companies for fill&finish operations. Similarly, Moderna entered into service agreements with Catalent, ROVI, Thermo Fisher, Recipharm, Samsung Biologics and other companies to fulfill the fill&finish demand for its COVID vaccine. We believe that service providers are likely to continue undertaking similar initiatives in the short-term to consolidate their presence in this field, distinguish themselves from the competition and cater to the diversified needs of their clientele. However, as the demand for fill/finish of pandemic vaccine decreases in the long-term, the contract manufacturing organizations will enter a phase of increased competition.
The biologics fill-finish manufacturing market opportunity for the CMOs is estimated to be USD 4 billion in 2022. With outsourcing being increasingly accepted as a viable / beneficial business model and the anticipated market growth for biologics, the opportunity for fill/finish contract manufacturers is expected to grow at a steady pace over the forecast period. Another key driver for the market growth for outsourcing of fill finish services of biologics is the rise in the number of small biopharmaceutical drug developers. The last few years have seen a rise in the number of investor funded startups for cell and gene therapy. As these drug developers move their products to clinical stages, the demand for outsourcing of biologic manufacturing and fill finish services will witness a healthy market growth.
Currently, Europe and Asia Pacific capture over 70% share of the overall biologics fill finish manufacturing market. In recent years, demand for fill finish services in Asia Pacific region has observed a tremendous increase. However, in the coming years, owing to the anticipated drug approvals, North America is likely to grow at a much faster rate as compared to other geographies.
A number of CMO / CDMOs have taken initiatives to expand their existing facilities and incorporate advanced technologies in order to meet the growing demand for fill/finish services, reduce cost of operation / increase efficiency, and comply to evolving safety and regulatory requirements. This market report analyzes the current installed capacity with the contract manufacturers for fill finish of biopharmaceuticals and the demand for commercial biologics till 2035. The current installed capacity is sufficient to meet the industry demand, but based on our data analysis this scenario is likely to change at the earliest by 2027. In order to meet the anticipated demand growth during the forecast period, we expect the contract manufacturers to continue to expand their facilities to strengthen the supply side.
Examples of key companies engaged in this industry (which have also been profiled in this report) include (in alphabetical order), AbbVie Contract Manufacturing, Asymchem, BioXcellence, BioPharma Solutions, BioReliance, Catalent Biologics, Charles River Laboratories, Fareva, Fresenius Kabi, GlaxoSmithKline, Hetero Drugs, Intas Pharmaceuticals, Lonza, Patheon, Pierre Fabre, Recipharm, Samsung Biologics, Syngene, Takara Bio, Wacker Biotech, and WuXi Biologics. This biologics fill finish manufacturing market report includes an easily searchable excel database of all the contract manufacturing organizations that have capability to fill finish biologics worldwide.
Several recent developments have taken place in the field of fill/finish manufacturing of biologics. We’ve outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we’ve outlined in our analysis.
The market research report presents an in-depth analysis of the various firms / contract manufacturing organizations that are engaged in this biologics fill finish manufacturing market, across different segments, as defined in the table below:
Market Segments | Details | |
Base Year |
2021 |
|
Forecast Period |
2022-2035 |
|
Market Size 2022 |
$ 4 billion |
|
CAGR |
8.4% |
|
Type of Packing Containers |
|
|
Type of Biologics |
|
|
Key Geographical Regions |
|
|
Therapeutic Area |
|
|
Company Size |
|
|
Geographical Region |
|
The market report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry. Amongst other elements, the market research report includes:
One of the key objectives of this fill finish manufacturing market report was to estimate the current market size and the future opportunity in the biologics fill-finish manufacturing market over the forecast period. Based on multiple parameters, such as growth of the overall biopharmaceutical market, cost of goods sold, direct manufacturing costs, share of other manufacturing costs and outsourcing trends related to fill/finish operations, we have provided an informed estimate of the likely evolution of the market in the short to mid-term and long term, for the forecast period 2022-2035. In order to provide a detailed future outlook, year-wise projections of the current and future opportunity have been further segmented on the basis of type of packaging containers (ampoules, cartridges, syringes and vials), type of biologics (antibodies, cell therapies, gene therapies, oligonucleotides, recombinant proteins, vaccines and other biologics), key therapeutic areas (autoimmune disorders, oncological disorders, cardiovascular disorders, infectious diseases and other disorders), scale of operation (preclinical / clinical and commercial), company size (large, mid-sized and small), and key geographical regions, (North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America). To account for the uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
The opinions and insights presented in this biologics fill finish manufacturing market report are backed by a deep understanding of key insights generated from both secondary and primary research. The perceptions presented in this market analysis were also influenced by discussions held with senior stakeholders in the industry. The market report features detailed transcripts of interviews held with the following industry and non-industry players:
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.
Contents
1 PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2 EXECUTIVE SUMMARY
3 INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biologics
3.3. Need for Outsourcing Biologics-related Operations
3.4. Introduction to Contract Manufacturing
3.5. Commonly Outsourced Operations in the Biopharmaceutical Industry
3.5.1. Biologics Fill/Finish Operations
3.6. Basic Guidelines for Selecting a Fill/Finish Service Provider
3.7. Advantages of Outsourcing Fill/Finish Operations
3.8. Risks and Challenges of Outsourcing Fill/Finish Operations
4 BIOLOGICS FILL/FINISH SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Biologics Fill/Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Fill-Finish Facilities
4.2.5. Analysis by Type of Packaging Container(s) Used
4.2.6. Analysis by Type of Biologic(s) Manufactured
4.2.7. Analysis by Scale of Operation
4.2.8. Analysis by Additional Drug Product-related Services Offered
4.2.9. Biologics Fill/Finish Service Providers: Information on Fill-Finish Capacity
5 COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters
5.3. Biologics Fill Finish Manufacturing Service Providers in North America
5.3.1. Players Offering Services for Ampoules
5.3.2. Players Offering Services for Cartridges
5.3.3. Players Offering Services for Syringes
5.3.4. Players Offering Services for Vials
5.4. Biologics Fill Finish Manufacturing Service Providers in Europe
5.4.1. Players Offering Services for Ampoules
5.4.2. Players Offering Services for Cartridges
5.4.3. Players Offering Services for Syringes
5.4.4. Players Offering Services for Vials
5.5. Biologics Fill Finish Manufacturing Service Providers in Asia Pacific and Rest of the World
5.5.1. Players Offering Services for Ampoules
5.5.2. Players Offering Services for Cartridges
5.5.3. Players Offering Services for Syringes
5.5.4. Players Offering Services for Vials
6 BIOLOGICS FILL FINISH CONTRACT MANUFACTURING COMPANIES IN NORTH AMERICA
6.1. Chapter Overview
6.2. AbbVie Contract Manufacturing
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Financial Information
6.2.4. Recent Developments and Future Outlook
6.3. BioPharma Solutions
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. BioReliance
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Financial Information
6.4.4. Recent Developments and Future Outlook
6.5. Catalent Biologics
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Financial Information
6.5.4. Recent Developments and Future Outlook
6.6. Patheon
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Financial Information
6.6.4. Recent Developments and Future Outlook
6.7. Charles River Laboratories
6.7.1. Company Overview
6.7.2. Fill / Finish Related Services
6.7.3. Financial Information
6.7.4. Recent Developments and Future Outlook
7 BIOLOGICS FILL FINISH CONTRACT MANUFACTURING COMPANIES IN EUROPE
7.1. Chapter Overview
7.2. Boehringer Ingelheim BioXcellence
7.2.1. Company Overview
7.2.2. Service Portfolio
7.2.3. Financial Information
7.2.4. Recent Developments and Future Outlook
7.3. Lonza
7.3.1. Company Overview
7.3.2. Service Portfolio
7.3.3. Financial Information
7.3.4. Recent Developments and Future Outlook
7.4. Pierre Fabre
7.4.1. Company Overview
7.4.2. Service Portfolio
7.4.3. Financial Information
7.4.4. Recent Developments and Future Outlook
7.5. Recipharm
7.5.1. Company Overview
7.5.2. Service Portfolio
7.5.3. Financial Information
7.5.4. Recent Developments and Future Outlook
7.6. Wacker Biotech
7.6.1. Company Overview
7.6.2. Service Portfolio
7.6.3. Financial Information
7.6.4. Recent Developments and Future Outlook
7.7. Fareva
7.7.1. Company Overview
7.7.2. Fill / Finish Related Services
7.7.3. Recent Developments and Future Outlook
7.8. Fresenius Kabi
7.8.1. Company Overview
7.8.2. Fill / Finish Related Services
7.8.3. Financial Information
7.8.4. Recent Developments and Future Outlook
7.9. GlaxoSmithKline
7.9.1. Company Overview
7.9.2. Fill / Finish Related Services
7.9.3. Financial Information
7.9.4. Recent Developments and Future Outlook
8 BIOLOGICS FILL FINISH CONTRACT MANUFACTURING COMPANIES IN ASIA PACIFIC
8.1. Chapter Overview
8.2. Asymchem
8.2.1. Company Overview
8.2.2. Service Portfolio
8.2.3. Financial Information
8.2.4. Recent Developments and Future Outlook
8.3. Samsung Biologics
8.3.1. Company Overview
8.3.2. Service Portfolio
8.3.3. Financial Information
8.3.4. Recent Developments and Future Outlook
8.4. Syngene
8.4.1. Company Overview
8.4.2. Service Portfolio
8.4.3. Financial Information
8.4.4. Recent Developments and Future Outlook
8.5. Takara Bio
8.5.1. Company Overview
8.5.2. Service Portfolio
8.5.3. Financial Information
8.5.4. Recent Developments and Future Outlook
8.6. WuXi Biologics
8.6.1. Company Overview
8.6.2. Service Portfolio
8.6.3. Financial Information
8.6.4. Recent Developments and Future Outlook
8.7. Hetero Drugs
8.7.1. Company Overview
8.7.2. Fill / Finish Related Services
8.7.3. Recent Developments and Future Outlook
8.8. Intas Pharmaceuticals
8.8.1. Company Overview
8.8.2. Fill / Finish Related Services
8.8.3. Recent Developments and Future Outlook
9 PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Biologics Fill / Finish Service Providers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Scale of Operation
9.3.4. Analysis by Type of Service(s) Offered
9.3.5. Analysis by Type of Process(es)
9.3.6. Analysis by Type of Biologic(s) Involved
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8. Analysis by Geographical Region
9.3.8.1. Intercontinental and Intracontinental Agreements
10 RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Biologics Fill/Finish Service Providers: Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Type of Packaging Container(s) Used
10.2.4. Analysis by Type of Service(s) Offered
10.2.5. Analysis by Type of Biologic(s) Involved and Scale of Operation
10.2.7. Most Active Players: Analysis by Number of Service(s) Offered
10.2.8. Analysis by Geographical Region
10.2.9. Expansions in North America: Analysis by Type of Service(s) Offered and Type of
Biologic(s) Involved
10.2.10. Expansions in Europe: Analysis by Type of Service(s) Offered and Type of Biologic(s) Involved
10.2.11. Expansions in Asia Pacific: Analysis by Type of Service(s) Offered and Type of Biologic(s) Involved
11 CAPACITY ANALYSIS
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Global Fill Finish Capacity (by Number of Units Filled)
11.3.1. Analysis by Type of Packaging Container
11.3.2. Analysis by Company Size
11.3.3. Analysis by Scale of Operation
11.3.4. Analysis by Location of Headquarters
11.3.5. Analysis by Location of Fill/Finish Facilities
11.4. Global Fill Finish Capacity (by Fill Volume)
11.4.1. Analysis by Type of Packaging Container
11.4.2. Analysis by Company Size
11.4.3. Analysis by Scale of Operation
11.4.4. Analysis by Location of Headquarters
11.4.5. Analysis by Location of Fill/Finish Facilities
11.5. Global Fill Finish Capacity for Ampoules (by Number of Units Filled)
11.5.1 Analysis by Company Size
11.5.2 Analysis by Scale of Operation
11.5.3. Analysis by Location of Headquarters
11.5.4 Analysis by Location of Fill/Finish Facilities
11.6. Global Fill Finish Capacity for Ampoules (by Fill Volume)
11.6.1. Analysis by Company Size
11.6.2. Analysis by Scale of Operation
11.6.3. Analysis by Location of Headquarters
11.6.4. Analysis by Location of Fill/Finish Facilities
11.7. Global Fill Finish Capacity for Cartridges (by Number of Units Filled)
11.7.1. Analysis by Company Size
11.7.2. Analysis by Scale of Operation
11.7.3. Analysis by Location of Headquarters
11.7.4. Analysis by Location of Fill/Finish Facilities
11.8. Global Fill Finish Capacity for Cartridges (by Fill Volume)
11.8.1. Analysis by Company Size
11.8.2. Analysis by Scale of Operation
11.8.3. Analysis by Location of Headquarters
11.8.4. Analysis by Location of Fill/Finish Facilities
11.9. Global Fill Finish Capacity for Syringes (by Number of Units Filled)
11.9.1 Analysis by Company Size
11.9.2 Analysis by Scale of Operation
11.9.3. Analysis by Location of Headquarters
11.9.4 Analysis by Location of Fill/Finish Facilities
11.10. Global Fill Finish Capacity for Syringes (by Fill Volume)
11.10.1. Analysis by Company Size
11.10.2. Analysis by Scale of Operation
11.10.3. Analysis by Location of Headquarters
11.10.4. Analysis by Location of Fill/Finish Facilities
11.11. Global Fill Finish Capacity for Vials (by Number of Units Filled)
11.11.1 Analysis by Company Size
11.11.2 Analysis by Scale of Operation
11.11.3. Analysis by Location of Headquarters
11.11.4. Analysis by Location of Fill/Finish Facilities
11.12. Global Fill Finish Capacity for Vials (by Fill Volume)
11.12.1. Analysis by Company Size
11.12.2. Analysis by Scale of Operation
11.12.3. Analysis by Location of Headquarters
11.12.4. Analysis by Location of Fill/Finish Facilities
11.13. Conclusion
12 DEMAND ANALYSIS
12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. Global Demand for Biologics Fill Finish Services
12.3.1. Analysis by Type of Packaging Container
12.3.2. Analysis by Type of Biologic
12.3.3. Analysis by Therapeutic Area
12.3.4. Analysis by Scale of Operation
12.3.5. Analysis by Company Size
12.3.6. Analysis by Geographical Location
12.4. Demand and Supply Analysis
13 KEY PERFORMANCE INDICATORS FOR BIOLOGIC MANUFACTURING AND FILL/FINISH
13.1. Chapter Overview
13.2. Biologics Manufacturing and Fill/Finish: Key Performance Indicators
13.2.1. Financial Indicators
13.2.1.1. Big Pharma Perspective
13.2.1.2. Contract Manufacturers’ Perspective
13.2.2. Process and Capability-related Indicators
13.2.2.1. Big Pharma Perspective
13.2.2.2. Contract Manufacturers’ Perspective
13.2.3. Market Reputation-related Indicators
13.2.3.1. Big Pharma Perspective
13.2.3.2. Contract Manufacturers’ Perspective
13.2.4. Other Important Performance Indicators
13.3.5. Conclusion
14 REGIONAL CAPABILITY ASSESSMENT
14.1. Chapter Overview
14.2. Assumptions and Key Parameters
14.3. Biologics Fill/Finish Capabilities in North America
14.4. Biologics Fill/Finish Capabilities in Europe
14.5. Biologics Fill/Finish Capabilities in Asia Pacific and Rest of the World
14.6. Regional Analysis of Installed Biologics Fill Finish Capacity
14.7.
15 MARKET SIZING AND OPPORTUNITY ANALYSIS
15.1. Chapter Overview
15.2. Forecast Methodology
15.3. Overall Biologics Fill Finish Manufacturing Market, 2022-2035
15.3.1. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Type of Packaging Container
15.3.2. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Type of Biologic
15.3.3. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Therapeutic Area
15.3.4. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Scale of Operation
15.3.5. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Company Size
15.3.6. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Geographical Region
15.3.5.1 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Countries
15.3.5.2. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Type of Packaging Container
15.3.5.3. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Type of Biologic
15.3.5.4. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Therapeutic Area
15.3.5.5. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Scale of Operation
15.3.5.6. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Company Size
15.3.5.7. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Countries
15.3.5.8. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Type of Packaging Container
15.3.5.9. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Type of Biologic
15.3.5.10. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Therapeutic Area
15.3.5.11. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Scale of Operation
15.3.5.12. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Company Size
15.3.5.13. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Countries
15.3.5.14. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Type of Packaging Container
15.3.5.15. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Type of Biologic
15.3.5.16. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Therapeutic Area
15.3.5.17. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.3.5.18. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Company Size
15.3.5.19. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Countries
15.3.5.20. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Type of Packaging Container
15.3.5.21. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.3.5.22. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.3.5.23. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.3.5.24. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.3.5.25. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Countries
15.3.5.26. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Packaging Container
15.3.5.27. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.3.5.28. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.3.5.29. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.3.5.30. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Company Size
15.4. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035
15.4.1. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Type of Biologic
15.4.2. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Therapeutic Area
15.4.3. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Scale of Operation
15.4.4. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Company Size
15.4.5. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Geographical Region
15.4.4.1. Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Type of Biologic
15.4.4.2. Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Therapeutic Area
15.4.4.3. Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Scale of Operation
15.4.4.4. Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Company Size
15.4.4.5. Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Type of Biologic
15.4.4.6. Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Therapeutic Area
15.4.4.7. Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Scale of Operation
15.4.4.8. Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Company Size
15.4.4.9. Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Type of Biologic
15.4.4.10. Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Therapeutic Area
15.4.4.11. Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.4.4.12. Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Company Size
15.4.4.13. Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.4.4.14. Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.4.4.15. Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.4.4.16. Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.4.4.17. Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.4.4.18. Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.4.4.19. Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.4.4.20. Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Company Size
15.5. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035
15.5.1. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Type of Biologic
15.5.2. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Therapeutic Area
15.5.3. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Scale of Operation
15.5.4. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Company Size
15.5.5. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Geographical Region
15.5.4.1. Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Type of Biologic
15.5.4.2. Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Therapeutic Area
15.5.4.3. Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Scale of Operation
15.5.4.4. Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Company Size
15.5.4.5. Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Type of Biologic
15.5.4.6. Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Therapeutic Area
15.5.4.7. Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Scale of Operation
15.5.4.8. Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Company Size
15.5.4.9. Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Type of Biologic
15.5.4.10. Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Therapeutic Area
15.5.4.11. Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.5.4.12. Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Company Size
15.5.4.13. Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.5.4.14. Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.5.4.15. Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.5.4.16. Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.5.4.17. Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.5.4.18. Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.5.4.19. Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.5.4.20. Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Company Size
15.6. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035
15.6.1. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Type of Biologic
15.6.2. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Therapeutic Area
15.6.3. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Scale of Operation
15.6.4. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Company Size
15.6.5. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Geographical Region
15.6.4.1. Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Type of Biologic
15.6.4.2. Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Therapeutic Area
15.6.4.3. Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Scale of Operation
15.6.4.4. Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Company Size
15.6.4.5. Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Type of Biologic
15.6.4.6. Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Therapeutic Area
15.6.4.7. Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Scale of Operation
15.6.4.8. Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Company Size
15.6.4.9. Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Type of Biologic
15.6.4.10. Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Therapeutic Area
15.6.4.11. Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.6.4.12. Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Company Size
15.6.4.13. Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.6.4.14. Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.6.4.15. Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.6.4.16. Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.6.4.17. Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.6.4.18. Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.6.4.19. Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.6.4.20. Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Company Size
15.7. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035
15.7.1. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Type of Biologic
15.7.2. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Therapeutic Area
15.7.3. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Scale of Operation
15.7.4. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Company Size
15.7.5. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Geographical Region
15.7.4.1. Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Type of Biologic
15.7.4.2. Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Therapeutic Area
15.7.4.3. Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Scale of Operation
15.7.4.4. Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Company Size
15.7.4.5. Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Type of Biologic
15.7.4.6. Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Therapeutic Area
15.7.4.7. Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Scale of Operation
15.7.4.8. Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Company Size
15.7.4.9. Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Type of Biologic 15.7.4.10.
15.7.4.11. Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.7.4.12. Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Company Size
15.7.4.13. Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.7.4.14. Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.7.4.15. Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.7.4.16. Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.7.4.17. Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.7.4.18. Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.7.4.19. Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.7.4.20. Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Company Size
16 FUTURE GROWTH OPPORTUNITIES
16.1. Chapter Overview
16.2. Growing Biopharmaceutical Pipeline
16.3. Increase in Outsourcing of Fill/Finish Activities
16.4. Rising Focus on Self-Administration of Drugs
16.5. Advances in Aseptic Fill/Finish Technologies
16.6. Growing Opportunities in the Asia Pacific Region
17 CASE STUDY: ROBOTIC SYSTEMS IN FILL/FINISH OPERATIONS
17.1. Chapter Overview
17.2. Contract Service Providers: List of Fill/Finish Equipment
17.3. Role of Robotic Systems in Fill/Finish Operations
17.3.1. Types of Robots Used in Pharmaceutical Operations
17.3.2. Key Considerations for Selecting a Robotic System
17.3.3. Advantages of Robotic Systems
17.3.4. Disadvantages of Robotic Systems
17.4. Companies Providing Robots for Use in the Pharmaceutical Industry
17.5. Companies Providing Isolator-based Aseptic Filling Systems
17.6. Concluding Remarks
18 CASE STUDY: READY TO USE PACKAGING COMPONENTS FOR ASEPTIC FILL FINISH
18.1. Chapter Overview
18.2. Role of Ready to Use Packaging Components in Aseptic Fill Finish Operations
18.2.1. Advantages of Ready to Use Packaging Components
18.2.2. Disadvantages of Ready to Use Packaging Components
18.3. Companies Providing Ready to Use Packaging Components
18.4. Conclusion
19 CONCLUDING REMARKS
20 EXECUTIVE INSIGHTS
20.1 Chapter Overview
20.2 IDT Biologika
20.2.1. Company Snapshot
20.2.1. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
20.3 Cytovance Biologics
20.3.1. Company Snapshot
20.3.2. Interview Transcript: Matt Delaney, Vice President of Business Development and Marketing
20.4. Syngene
20.4.1. Company Snapshot
20.4.2. Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development
20.5 oncomed manufacturing
20.5.1. Company Snapshot
20.5.2. Interview Transcript: Ales Sima, Business Development Manager
20.6 Yposkesi
20.6.1. Company Snapshot
20.6.2. Interview Transcript: Amit, Technology Watch Manager
20.7 HALIX
20.7.1. Company Snapshot
20.7.2. Interview Transcript: Jos Vergeest, International Business Developer
21 APPENDIX 1: TABULATED DATA
22 APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 3.1 Various Types of Biologics
Figure 3.2 Types of Third-Party Service Providers
Figure 3.3 Commonly Outsourced Operations in the Biopharmaceutical Industry
Figure 3.4 Steps Involved in Fill/Finish of Biologics
Figure 3.5 Key Considerations for Selecting a CMO Partner
Figure 3.6 Risks and Challenges of Outsourcing Biologics Fill / Finish Operations
Figure 4.1 Biologics Fill/Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Biologics Fill/Finish Service Providers: Distribution by Company Size
Figure 4.3 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 4.4 Biologics Fill/Finish Service Providers: Distribution by Location of Fill/Finish Facilities
Figure 4.5 Biologics Fill/Finish Service Providers: Distribution by Type of Packaging Container(s) Used
Figure 4.6 Biologics Fill/Finish Service Providers: Distribution by Type of Biologic(s) Manufactured and Type of Packaging Container(s) Used
Figure 4.7 Biologics Fill/Finish Service Providers: Distribution by Scale of Operation
Figure 4.8 Biologics Fill/Finish Service Providers: Distribution by Additional Drug Product-related Services Offered
Figure 5.1 Company Competitiveness Analysis: Biologics Fill/Finish Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: Players Offering Services for Ampoules (North America)
Figure 5.3 Company Competitiveness Analysis: Players Offering Services for Cartridges (North America)
Figure 5.4 Company Competitiveness Analysis: Players Offering Services for Syringes (North America)
Figure 5.5 Company Competitiveness Analysis: Players Offering Services for Vials (North America)
Figure 5.6 Company Competitiveness Analysis: Biologics Fill/Finish Service Providers in (Europe)
Figure 5.7 Company Competitiveness Analysis: Players Offering Services for Ampoules (Europe)
Figure 5.8 Company Competitiveness Analysis: Players Offering Services for Cartridges (Europe)
Figure 5.9 Company Competitiveness Analysis: Players Offering Services for Syringes (Europe)
Figure 5.10 Company Competitiveness Analysis: Players Offering Services for Vials (Europe)
Figure 5.11 Company Competitiveness Analysis: Biologics Fill/Finish Service Providers in (Asia Pacific and Rest of the World)
Figure 5.12 Company Competitiveness Analysis: Players Offering Services for Ampoules (Asia Pacific and Rest of the World)
Figure 5.13 Company Competitiveness Analysis: Players Offering Services for Cartridges (Asia Pacific and Rest of World)
Figure 5.14 Company Competitiveness Analysis: Players Offering Services for Syringes (Asia Pacific and Rest of the World)
Figure 5.15 Company Competitiveness Analysis: Players Offering Services for Vials (Asia Pacific and Rest of the World)
Figure 6.1 AbbVie: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 6.2 Baxter International: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 6.3 Merck: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 6.4 Catalent Biologics: Annual Revenues, FY 2017-FY 2022 (USD Billion)
Figure 6.5 Thermo Fisher Scientific: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 6.6 Charles River Laboratories: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 7.1 Boehringer Ingelheim: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 7.2 Lonza: Annual Revenues, 2017-H1 2022 (CHF Billion)
Figure 7.3 Pierre Fabre: Annual Revenues, FY 2018-FY 2021 (EUR Billion)
Figure 7.4 Recipharm: Annual Revenues, FY 2017-FY 2020 (SEK Billion)
Figure 7.6 Wacker Chemie: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 7.7 Fresenius Kabi: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 7.8 Glaxo SmithKline: Annual Revenues, 2017-H1 2022 (GBP Billion)
Figure 8.1 Asymchem: Annual Revenues, 2017-2020 (USD Billion)
Figure 8.2 Samsung Biologics: Annual Revenues, 2017-H1 2022 (KRW Billion)
Figure 8.3 Syngene: Annual Revenues, FY 2017-FY 2022 (INR Million)
Figure 8.4 Takara Bio: Annual Revenues, 2017-H1 2022 (JPY Billion)
Figure 8.5 WuXi Biologics: Annual Revenues, 2017-H1 2022 (RMB Million)
Figure 9.1 Partnerships and Collaborations: Cumulative Trend by Year, 2013-2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Scale of Operation
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Service(s) Offered
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Process(es)
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Biologic(s) Involved
Figure 9.7 Most Active Players: Distribution by Number of Partnerships
Figure 9.8 Partnerships and Collaborations: Distribution by Geographical Region
Figure 9.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Expansions: Distribution by Year of Expansion, 2013-2022 (till August)
Figure 10.2 Expansions: Distribution by Type of Expansion
Figure 10.3 Expansions: Distribution by Type of Packaging Container(s) Used
Figure 10.4 Expansions: Distribution by Type of Expansion and Type of Service(s) Offered
Figure 10.5 Expansions: Distribution by Type of Biologic(s) Involved
Figure 10.6 Expansions: Distribution by Type of Biologic(s) Involved and Scale of Operation
Figure 10.7 Expansions: Distribution by Geographical Region
Figure 10.8 Expansions: Distribution by Location of Expansion Project
Figure 10.9 Most Active Players: Distribution by Number of Expansions
Figure 10.10 Expansions in North America: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Figure 10.11 Expansions in Europe: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Figure 10.12 Expansions in Asia Pacific and Rest of the World: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Figure 11.1 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Figure 11.2 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Figure 11.3 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Figure 11.4 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Figure 11.5 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.6 Global Fill/Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Liters)
Figure 11.7 Global Fill/Finish Capacity (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.8 Global Fill/Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.9 Global Fill/Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.10 Global Fill/Finish Capacity (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.11 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.12 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.13 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.14 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.15 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.16 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.17 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.18 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.19 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.20 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.21 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.22 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.23 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.24 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.25 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.26 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.27 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.28 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.29 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.30 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.31 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.32 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.33 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.34 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.35 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.36 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.37 Global Fill/Finish Capacity for Syringes (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.38 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.39 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.40 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.41 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.42 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.43 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.44 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.45 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.46 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.47 Global Fill/Finish Capacity for Vials (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.48 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.49 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.50 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 12.1 Global Demand for Biologics Fill Finish Manufacturing (Million Liters)
Figure 12.2 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Type of Packaging Container (Liters)
Figure 12.3 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Type of Biologic (Liters)
Figure 12.4 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Therapeutic Area (Liters)
Figure 12.5 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Scale of Operation (Liters)
Figure 12.6 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Company Size (Liters)
Figure 12.7 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Geographical Location (Liters)
Figure 12.8 Global Biologics Fill Finish Manufacturing: Demand and Supply, 2022-2035
Figure 13.1 Biologics Manufacturing and Fill/Finish: Key Performance Indicators (KPIs)
Figure 13.2 Financial Indicators: Comparative Analysis of KPIs Considered by Big Pharma Companies
Figure 13.3 Financial Indicators: Big Pharma Perspective
Figure 13.4 Financial Indicators: Contract Manufacturers’ Perspective
Figure 13.5 Process / Capability-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.6 Process / Capability-related Indicators: Big Pharma Perspective
Figure 13.7 Process / Capability-related Indicators: Contract Manufacturers’ Perspective
Figure 13.8 Market Reputation-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.9 Market Reputation-related Indicators: Big Pharma Perspective
Figure 13.10 Market Reputation-related Indicators: Contract Manufacturers’ Perspective
Figure 13.11 Other Performance Indicators: Contract Manufacturers’ Perspective
Figure 14.1 Regional Capability Assessment: Biologic Fill/Finish Capabilities in North America
Figure 14.2 Regional Capability Assessment: Biologic Fill/Finish Capabilities in Europe
Figure 14.3 Regional Capability Assessment: Biologic Fill/Finish Capabilities in Asia Pacific and Rest of the World
Figure 14.4 Regional Capability Analysis: Biologic Fill/Finish Installed Capacity in Different Geographical Regions
Figure 14.4 Regional Capability Assessment: Comparison of Capabilities across Different Regions
Figure 15.1 Overall Biologics Fill Finish Manufacturing Market, 2022-2035 (USD Billion)
Figure 15.2 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.3 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.4 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.5 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.6 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.7 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.8 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Countries (USD Million)
Figure 15.9 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 1510 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.11 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.12 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.13 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.14 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Countries (USD Million)
Figure 15.15 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.16 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.17 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Therapeutic Are (USD Million)
Figure 15.18 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.19 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.20 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Countries (USD Million)
Figure 15.21 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.22 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.23 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.24 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.25 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.26 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Countries (USD Million)
Figure 15.27 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.28 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.29 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.30 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.31 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.32 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Countries (USD Million)
Figure 15.33 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.34 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.35 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.36 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.37 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.38 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035 (USD Million)
Figure 15.39 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.40 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.41 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.42 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.43 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.44 Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.45 Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.46 Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.47 Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.48 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.49 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.50 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.51 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.52 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.53 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.54 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.55 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.56 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.57 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.58 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.59 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.60 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.61 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.62 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.63 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.64 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035(USD Million)
Figure 15.65 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.66 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.67 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.68 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.69 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.70 Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.71 Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.72 Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.73 Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.74 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.75 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.76 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.77 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.78 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.79 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.80 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.81 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.82 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.83 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.84 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.85 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.86 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.87 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.88 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.89 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.90 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035 (USD Million)
Figure 15.91 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.92 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.93 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.94 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.95 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.96 Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.97 Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.98 Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.99 Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.100 Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.101 Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.102 Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.103 Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.104 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.105 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.106 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.107 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.108 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.109 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.110 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.111 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.112 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.113 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.114 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.115 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.116 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035(USD Million)
Figure 15.117 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.118 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.119 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.120 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.121 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.122 Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.123 Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.124 Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.125 Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.126 Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.127 Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.128 Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.129 Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.130 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.131 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.132 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.133 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.134 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.135 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.136 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.137 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.138 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.139 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.140 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.141 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 16.1 Growth Opportunities for Biologics Fill/Finish Service Providers
Figure 16.2 Drug Products Approved by the FDA, 2011-2021
Figure 17.1 Key Considerations for Selecting a Robotic System
Figure 17.2 Advantages of Robotic Systems in Pharmaceutical Operations
Figure 18.1 Key Drivers of Ready-to-Use Platform
Figure 19.1 Concluding Remarks: Current Biologic Fill/Finish Service Providers Market Landscape Summary
Figure 19.2 Concluding Remarks: Recent Partnerships
Figure 19.3 Concluding Remarks: Recent Expansions
Figure 19.4 Concluding Remarks: Capacity Analysis
Figure 19.5 Concluding Remarks: Demand Analysis
Figure 19.6 Concluding Remarks: Market Sizing and Opportunity Analysis for Biologic Fill Finish Manufacturing Market
Table 3.1 Best-Selling Drugs of 2022
Table 4.1 Biologics Fill/Finish Service Providers: List of Companies
Table 4.2 Biologics Fill/Finish Service Providers: Information on Type of Packaging Container(s) Used
Table 4.3 Biologics Fill/Finish Service Providers: Information on Type of Biologic(s) Manufactured
Table 4.4 Biologics Fill/Finish Service Providers: Information on Scale of Operation
Table 4.5 Biologics Fill/Finish Service Providers: Information on Additional Drug Product-related Services Offered
Table 4.6 Biologics Fill/Finish Service Providers: Information on Fill/Finish Capacity
Table 6.1 Biologics Fill/Finish Service Providers in North America: List of Profiled Companies
Table 6.2 AbbVie Contract Manufacturing: Company Overview
Table 6.3 AbbVie Contract Manufacturing: Overview of Service Portfolio
Table 6.4 AbbVie Contract Manufacturing: Overview of Fill Finish Manufacturing
Table 6.5 AbbVie Contract Manufacturing: Sterile Manufacturing Facilities
Table 6.6 AbbVie Contract Manufacturing: Recent Developments and Future Outlook
Table 6.7 BioPharma Solutions: Company Overview
Table 6.8 BioPharma Solutions: Overview of Service Portfolio
Table 6.9 BioPharma Solutions: Overview of Fill Finish Manufacturing
Table 6.8 BioPharma Solutions: Sterile Manufacturing Facilities
Table 6.10 BioPharma Solutions: Recent Developments and Future Outlook
Table 6.11 BioReliance: Company Overview
Table 6.12 BioReliance: Overview of Service Portfolio
Table 6.13 BioReliance: Overview of Fill Finish Manufacturing
Table 6.14 BioReliance: Sterile Manufacturing Facilities
Table 6.15 BioReliance: Recent Developments and Future Outlook
Table 6.16 Catalent Biologics: Company Overview
Table 6.17 Catalent Biologics: Overview of Service Portfolio
Table 6.18 Catalent Biologics: Overview of Fill Finish Manufacturing
Table 6.19 Catalent Biologics: Sterile Manufacturing Facilities
Table 6.20 Catalent Biologics: Recent Developments and Future Outlook
Table 6.21 Patheon: Company Overview
Table 6.22 Patheon: Overview of Service Portfolio
Table 6.23 Patheon: Overview of Fill Finish Manufacturing
Table 6.24 Patheon: Sterile Manufacturing Facilities
Table 6.25 Patheon: Recent Developments and Future Outlook
Table 6.26 Charles River Laboratories: Company Snapshot
Table 6.27 Charles River Laboratories: Overview of Fill Finish Manufacturing
Table 6.28 Charles River Laboratories: Recent Developments and Future Outlook
Table 7.1 Biologics Fill/Finish Service Providers in Europe: List of Profiled Companies
Table 7.2 Boehringer Ingelheim BioXcellence: Company Overview
Table 7.3 Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Table 7.4 Boehringer Ingelheim BioXcellence: Overview of Fill Finish Manufacturing
Table 7.5 Boehringer Ingelheim BioXcellence: Sterile Manufacturing Facilities
Table 7.6 Boehringer Ingelheim BioXcellence: Recent Developments and Future Outlook
Table 7.7 Lonza: Company Overview
Table 7.8 Lonza: Overview of Service Portfolio
Table 7.9 Lonza: Overview of Fill Finish Manufacturing
Table 7.10 Lonza: Sterile Manufacturing Facilities
Table 7.11 Lonza: Recent Developments and Future Outlook
Table 7.12 Pierre Fabre: Company Overview
Table 7.13 Pierre Fabre: Overview of Service Portfolio
Table 7.14 Pierre Fabre: Overview of Fill Finish Manufacturing
Table 7.15 Pierre Fabre: Sterile Manufacturing Facilities
Table 7.16 Pierre Fabre: Recent Developments and Future Outlook
Table 7.17 Recipharm: Company Overview
Table 7.18 Recipharm: Overview of Service Portfolio
Table 7.19 Recipharm: Overview of Fill Finish Manufacturing
Table 7.20 Recipharm: Sterile Manufacturing Facilities
Table 7.21 Recipharm: Recent Developments and Future Outlook
Table 7.22 Wacker Biotech: Company Overview
Table 7.23 Wacker Biotech: Overview of Service Portfolio
Table 7.24 Wacker Biotech: Overview of Fill/Finish Related Services
Table 7.25 Wacker Biotech: Sterile Manufacturing Facilities
Table 7.26 Wacker Biotech: Recent Developments and Future Outlook
Table 7.27 Fareva: Company Overview
Table 7.28 Fareva: Overview of Fill Finish Manufacturing
Table 7.29 Fareva: Recent Developments and Future Outlook
Table 7.30 Fresenius Kabi: Company Overview
Table 7.31 Fresenius Kabi: Overview of Fill Finish Manufacturing
Table 7.32 Glaxo SmithKline: Company Overview
Table 7.33 Glaxo SmithKline: Overview of Fill Finish Manufacturing
Table 7.34 Glaxo SmithKline: Recent Developments and Future Outlook
Table 8.1 Biologics Fill/Finish Service Providers in Asia Pacific: List of Profiled Companies
Table 8.2 Asymchem: Company Overview
Table 8.3 Asymchem: Overview of Service Portfolio
Table 8.4 Asymchem: Overview of Fill Finish Manufacturing
Table 8.5 Asymchem: Sterile Manufacturing Facilities
Table 8.6 Asymchem: Recent Developments and Future Outlook
Table 8.7 Samsung Biologics: Company Overview
Table 8.8 Samsung Biologics: Overview of Service Portfolio
Table 8.9 Samsung Biologics: Overview of Fill Finish Manufacturing
Table 8.10 Samsung Biologics: Recent Developments and Future Outlook
Table 8.11 Syngene: Company Overview
Table 8.12 Syngene: Overview of Service Portfolio
Table 8.13 Syngene: Overview of Fill Finish Manufacturing
Table 8.14 Syngene: Recent Developments and Future Outlook
Table 8.15 Takara Bio: Company Overview
Table 8.16 Takara Bio: Overview of Service Portfolio
Table 8.17 Takara Bio: Overview of Fill Finish Manufacturing
Table 8.18 Takara Bio: Recent Developments and Future Outlook
Table 8.19 WuXi Biologics: Company Overview
Table 8.20 WuXi Biologics: Overview of Services Portfolio
Table 8.21 Wuxi Biologics: Overview of Fill Finish Manufacturing
Table 8.22 WuXi Biologics: Sterile Manufacturing Facilities
Table 8.23 WuXi Biologics: Recent Developments and Future Outlook
Table 8.24 Hetero Drugs: Company Overview
Table 8.25 Hetero Drugs: Overview of Fill Finish Manufacturing
Table 8.26 Intas Pharmaceuticals: Company Overview
Table 8.27 Intas Pharmaceuticals: Overview of Fill Finish Manufacturing
Table 9.1 Biologics Fill/Finish Service Providers: Partnerships and Collaborations, 2013-2022
Table 9.2 Partnerships and Collaborations: Information on Type of Service(s) Offered, 2013-2022
Table 9.3 Partnerships and Collaborations: Information on Type of Biologic(s) Involved, 2013-2022
Table 10.1 Biologics Fill/Finish Service Providers: Recent Expansions, 2013-2022
Table 10.2 Expansions, 2013-2022: Information on Type of Packaging Container(s) Used
Table 10.3 Recent Expansions, 2013-2022: Information on Type of Service(s) Offered
Table 10.4 Expansions, 2013-2022: Information on Type of Biologic(s) Involved
Table 11.1 Average Fill/Finish Capacity for Ampoules (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.2 Average Fill/Finish Capacity for Cartridges (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.3 Average Fill/Finish Capacity for Syringes (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.4 Average Fill/Finish Capacity for Vials (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.5 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size
Table 11.6 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size
Table 11.7 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size
Table 11.8 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size
Table 11.9 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 11.10 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size
Table 11.11 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size
Table 11.12 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Company Size
Table 12.1 Biologics Fill/Finish Outsourcing: Annual Supply, 2022-2035 (Million Liters)
Table 16.1 Patent Expiry of Biologics, 2021-2023
Table 17.1 Biologics Fill/Finish Service Providers: Information on Fill/Finish Equipment
Table 17.2 List of Pharmaceutical Robotics Manufacturers
Table 17.3 Isolator based Aseptic Filling Systems: Information on Compatible Primary Container
Table 18.1 List of Companies Supplying Ready-to-Use Packaging Components
Table 19.1 Biologics Fill/Finish Service Providers: Summary of the Report
Table 21.1 Biologics Fill/Finish Service Providers: Distribution by Year of Establishment
Table 21.2 Biologics Fill/Finish Service Providers: Distribution by Company Size
Table 21.3 Biologics Fill/Finish Service Providers: Distribution by Location of Headquarters
Table 21.4 Biologics Fill/Finish Service Providers: Distribution by Location of Fill/Finish Facilities
Table 21.5 Biologics Fill/Finish Service Providers: Distribution by Type of Packaging Container(s) Used
Table 21.6 Biologics Fill/Finish Service Providers: Distribution by Type of Biologic(s) Manufactured and Type of Packaging Container(s) Used
Table 21.7 Biologics Fill/Finish Service Providers: Distribution by Scale of Operation
Table 21.8 Biologics Fill/Finish Service Providers: Distribution by Type of Additional Drug Product-related Services Offered
Table 21.9 AbbVie: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.10 Baxter International: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.11 Merck: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.12 Catalent Biologics: Annual Revenues, FY 2017-FY 2022 (USD Billion)
Table 21.13 Thermo Fisher Scientific: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.14 Charles River Laboratories: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.15 Boehringer Ingelheim: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.16 Lonza: Annual Revenues, 2017-H1 2022 (CHF Billion)
Table 21.17 Pierre Fabre: Annual Revenues, FY 2018-FY 2021 (EUR Billion)
Table 21.18 Recipharm: Annual Revenues, FY 2017-FY 2020 (SEK Billion)
Table 21.19 Wacker Chemie: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.20 Fresenius Kabi: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.21 Glaxo SmithKline: Annual Revenues, 2017-H1 2022 (GBP Billion)
Table 21.22 Asymchem: Annual Revenues, FY 2017-FY 2020 (USD Billion)
Table 21.23 Samsung Biologics: Annual Revenues, 2017-H1 2022 (KRW Billion)
Table 21.24 Syngene: Annual Revenues, 2017-2022 (INR Million)
Table 21.25 Takara Bio: Annual Revenues, 2017-H1 2022 (JPY Billion)
Table 21.26 WuXi Biologics: Annual Revenues, 2017-H1 2022 (RMB Million)
Table 21.27 Partnerships and Collaborations: Cumulative Year-wise Trend, 2013-2022
Table 21.28 Partnerships and Collaborations: Distribution by Type of Partnership
Table 21.29 Partnerships and Collaborations: Distribution by Scale of Operation
Table 21.30 Partnerships and Collaborations: Distribution by Type of Service(s) Offered
Table 21.31 Partnerships and Collaborations: Distribution by Type of Process(es)
Table 21.32 Partnerships and Collaborations: Distribution by Types of Biologic(s) Involved
Table 21.33 Most Active Players: Distribution by Number of Partnerships
Table 21.34 Partnerships and Collaborations: Distribution by Geographical Region
Table 21.35 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 21.36 Expansions: Distribution by Year of Expansion, 2013-2022
Table 21.37 Expansions: Distribution by Type of Expansion
Table 21.38 Expansions: Distribution by Type of Packaging Container(s) Used
Table 21.39 Expansions: Distribution by Type of Expansion and Type of Service(s) Offered
Table 21.40 Expansions: Distribution by Type of Biologic(s) Involved
Table 21.41 Expansions: Distribution by Type of Biologic and Scale of Operation
Table 21.42 Expansions: Distribution by Geographical Location
Table 21.43 Expansions: Distribution by Location of Expansion Project
Table 21.44 Most Active Players: Distribution by Number of Expansions
Table 21.45 Expansions in North America: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Table 21.46 Expansions in Europe: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Table 21.47 Expansions in Asia Pacific: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Table 21.48 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Table 21.49 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Table 21.50 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Table 21.51 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Table 21.52 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.53 Global Fill/Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Kilo Liters)
Table 21.54 Global Fill/Finish Capacity (by Fill Volume): Distribution by Company Size (Kilo Liters)
Table 21.55 Global Fill/Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Kilo Liters)
Table 21.56 Global Fill/Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Kilo Liters)
Table 21.57 Global Fill/Finish Capacity (by Fill Volume): Distribution by Location of Fill /
Table 21.58 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.59 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.60 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.61 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.62 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Table 21.63 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.64 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.65 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution byLocation of Fill/Finish Facilities (Liters)
Table 21.66 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.67 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.68 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.69 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.70 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Table 21.71 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.72 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.73 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 21.74 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 21.75 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.76 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.77 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.78 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Table 21.79 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.80 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.81 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 21.82 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.83 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.84 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.85 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.86 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Liters)
Table 21.87 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.88 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.89 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 21.90 Global Demand for Biologics Fill Finish Manufacturing (Million Liters)
Table 21.91 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Type of Packaging Container (Kilo Liters)
Table 21.92 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Type of Biologic (Kilo Liters)
Table 21.93 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Therapeutic Area (Kilo Liters)
Table 21.94 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Scale of Operation (Kilo Liters)
Table 21.95 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Company Size (Kilo Liters)
Table 21.96 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Geographical Location (Kilo Liters)
Table 21.97 Global Biologics Fill Finish Manufacturing: Demand and Supply, 2022-2035
Table 21.98 Overall Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Billion)
Table 21.99 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.100 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.101 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.102 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.103 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.104 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.105 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.106 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.107 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.108 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.109 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.110 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.111 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.112 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.113 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.114 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.115 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.116 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.117 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.118 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.119 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.120 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.121 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.122 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.123 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.124 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.125 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.126 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.127 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.128 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.129 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.130 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.131 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.132 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.133 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.134 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.135 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.136 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.137 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.138 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.139 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.140 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.141 Biologics Fill Finish Manufacturing Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.142 Biologics Fill Finish Manufacturing Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.143 Biologics Fill Finish Manufacturing Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale pf Operation (USD Million)
Table 21.144 Biologics Fill Finish Manufacturing Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.145 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.146 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.147 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.148 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.149 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.150 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.151 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.152 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.153 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.154 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.155 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.156 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.157 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.158 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.159 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.160 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.161 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.162 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.163 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.164 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.165 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.166 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.167 Biologics Fill Finish Manufacturing Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.168 Biologics Fill Finish Manufacturing Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.169 Biologics Fill Finish Manufacturing Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.170 Biologics Fill Finish Manufacturing Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.171 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.172 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.173 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.174 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.175 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.176 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.177 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.178 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.179 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.180 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.181 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.182 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.183 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.184 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.185 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.186 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.187 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.188 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.189 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.190 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.191 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.192 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.193 Biologics Fill Finish Manufacturing Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.194 Biologics Fill Finish Manufacturing Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.195 Biologics Fill Finish Manufacturing Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.196 Biologics Fill Finish Manufacturing Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.197 Biologics Fill Finish Manufacturing Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.198 Biologics Fill Finish Manufacturing Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.199 Biologics Fill Finish Manufacturing Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.200 Biologics Fill Finish Manufacturing Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.201 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.202 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.203 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.204 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.205 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.206 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.207 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.208 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.209 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.210 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.211 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.212 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.213 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.214 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.215 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.216 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.217 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.218 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.219 Biologics Fill Finish Manufacturing Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.220 Biologics Fill Finish Manufacturing Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.221 Biologics Fill Finish Manufacturing Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.222 Biologics Fill Finish Manufacturing Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.223 Biologics Fill Finish Manufacturing Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.224 Biologics Fill Finish Manufacturing Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.225 Biologics Fill Finish Manufacturing Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.226 Biologics Fill Finish Manufacturing Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.227 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.228 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.229 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.230 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.231 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.232 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.233 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.234 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.235 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.236 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.237 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.238 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.239 Drug Product Pipeline Approved by the FDA, 2011-2021
The following companies and organizations have been mentioned in the report:
Source 1: https://www.biopharmatrend.com/post/67-will-small-molecules-sustain-pharmaceutical-race-with-biologics/
Source 2: https://www.pharmasalmanac.com/articles/meeting-the-changing-demands-for-sterile-fill-finish-operations